These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
491 related articles for article (PubMed ID: 34082008)
1. A prospective study on the consequences of SARS-CoV-2 infection on the heart of young adult competitive athletes: Implications for a safe return-to-play. Cavigli L; Frascaro F; Turchini F; Mochi N; Sarto P; Bianchi S; Parri A; Carraro N; Valente S; Focardi M; Cameli M; Bonifazi M; D'Ascenzi F Int J Cardiol; 2021 Aug; 336():130-136. PubMed ID: 34082008 [TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 infection and return to play in junior competitive athletes: is systematic cardiac screening needed? Cavigli L; Cillis M; Mochi V; Frascaro F; Mochi N; Hajdarevic A; Roselli A; Capitani M; Alvino F; Giovani S; Lisi C; Cappellini MT; Colloca RA; Mandoli GE; Valente S; Focardi M; Cameli M; Bonifazi M; D'Ascenzi F Br J Sports Med; 2022 Mar; 56(5):264-270. PubMed ID: 34844952 [TBL] [Abstract][Full Text] [Related]
3. Low prevalence of cardiac abnormalities in competitive athletes at return-to-play after COVID-19. Maestrini V; Penza M; Filomena D; Birtolo LI; Monosilio S; Lemme E; Squeo MR; Mango R; Di Gioia G; Serdoz A; Fiore R; Fedele F; Pelliccia A; Di Giacinto B J Sci Med Sport; 2023 Jan; 26(1):8-13. PubMed ID: 36372623 [TBL] [Abstract][Full Text] [Related]
4. Return to Play after SARS-CoV-2 Infection in Competitive Athletes of Distinct Sport Disciplines in Italy: A FMSI (Italian Federation of Sports Medicine) Study. Casasco M; Iellamo F; Scorcu M; Parisi A; Tavcar I; Brugin E; Martini B; Fossati C; Pigozzi F J Cardiovasc Dev Dis; 2022 Feb; 9(2):. PubMed ID: 35200712 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of Inflammatory Heart Disease Among Professional Athletes With Prior COVID-19 Infection Who Received Systematic Return-to-Play Cardiac Screening. Martinez MW; Tucker AM; Bloom OJ; Green G; DiFiori JP; Solomon G; Phelan D; Kim JH; Meeuwisse W; Sills AK; Rowe D; Bogoch II; Smith PT; Baggish AL; Putukian M; Engel DJ JAMA Cardiol; 2021 Jul; 6(7):745-752. PubMed ID: 33662103 [TBL] [Abstract][Full Text] [Related]
6. Cardiac Troponin Testing as a Component of Return to Play Cardiac Screening in Young Competitive Athletes Following SARS-CoV-2 Infection. Moulson N; Petek BJ; Churchill TW; Drezner JA; Harmon KG; Kliethermes SA; Mellacheruvu P; Patel MR; Baggish AL; J Am Heart Assoc; 2022 Aug; 11(16):e025369. PubMed ID: 35929475 [TBL] [Abstract][Full Text] [Related]
8. Cardiopulmonary examinations of athletes returning to high-intensity sport activity following SARS-CoV-2 infection. Babity M; Zamodics M; Konig A; Kiss AR; Horvath M; Gregor Z; Rakoczi R; Kovacs E; Fabian A; Tokodi M; Sydo N; Csulak E; Juhasz V; Lakatos BK; Vago H; Kovacs A; Merkely B; Kiss O Sci Rep; 2022 Dec; 12(1):21686. PubMed ID: 36522351 [TBL] [Abstract][Full Text] [Related]
9. Is extensive cardiopulmonary screening useful in athletes with previous asymptomatic or mild SARS-CoV-2 infection? Gervasi SF; Pengue L; Damato L; Monti R; Pradella S; Pirronti T; Bartoloni A; Epifani F; Saggese A; Cuccaro F; Bianco M; Zeppilli P; Palmieri V Br J Sports Med; 2021 Jan; 55(1):54-61. PubMed ID: 33020140 [TBL] [Abstract][Full Text] [Related]
10. COVID-19 in German Competitive Sports: Protocol for a Prospective Multicenter Cohort Study (CoSmo-S). Niess AM; Widmann M; Gaidai R; Gölz C; Schubert I; Castillo K; Sachs JP; Bizjak D; Vollrath S; Wimbauer F; Vogel A; Keller K; Burgstahler C; Quermann A; Kerling A; Schneider G; Zacher J; Diebold K; Grummt M; Beckendorf C; Buitenhuis J; Egger F; Venhorst A; Morath O; Barsch F; Mellwig KP; Oesterschlink J; Wüstenfeld J; Predel HG; Deibert P; Friedmann-Bette B; Mayer F; Hirschmüller A; Halle M; Steinacker JM; Wolfarth B; Meyer T; Böttinger E; Flechtner-Mors M; Bloch W; Haller B; Roecker K; Reinsberger C Int J Public Health; 2022; 67():1604414. PubMed ID: 35197815 [No Abstract] [Full Text] [Related]
11. Systematic Cardiovascular Screening in Olympic Athletes before and after SARS-CoV-2 Infection. Maestrini V; Filomena D; Birtolo LI; Serdoz A; Fiore R; Tatangelo M; Lemme E; Squeo MR; Mango R; Di Gioia G; Fedele F; Gualdi G; Spataro A; Pelliccia A; Di Giacinto B J Clin Med; 2022 Jun; 11(12):. PubMed ID: 35743567 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of Clinical and Subclinical Myocarditis in Competitive Athletes With Recent SARS-CoV-2 Infection: Results From the Big Ten COVID-19 Cardiac Registry. Daniels CJ; Rajpal S; Greenshields JT; Rosenthal GL; Chung EH; Terrin M; Jeudy J; Mattson SE; Law IH; Borchers J; Kovacs R; Kovan J; Rifat SF; Albrecht J; Bento AI; Albers L; Bernhardt D; Day C; Hecht S; Hipskind A; Mjaanes J; Olson D; Rooks YL; Somers EC; Tong MS; Wisinski J; Womack J; Esopenko C; Kratochvil CJ; Rink LD; JAMA Cardiol; 2021 Sep; 6(9):1078-1087. PubMed ID: 34042947 [TBL] [Abstract][Full Text] [Related]
13. Coronavirus Disease 2019 and the Athletic Heart: Emerging Perspectives on Pathology, Risks, and Return to Play. Kim JH; Levine BD; Phelan D; Emery MS; Martinez MW; Chung EH; Thompson PD; Baggish AL JAMA Cardiol; 2021 Feb; 6(2):219-227. PubMed ID: 33104154 [TBL] [Abstract][Full Text] [Related]
14. Implications of SARS-CoV-2-Associated Myocarditis in the Medical Evaluation of Athletes. Raukar NP; Cooper LT Sports Health; 2021 Mar; 13(2):145-148. PubMed ID: 33201768 [TBL] [Abstract][Full Text] [Related]
15. Electrocardiographic findings in young competitive athletes during acute SARS-CoV-2 infection. Petek BJ; Moulson N; Baggish AL; Drezner JA; Harmon KG; Klein CF; Kliethermes SA; Patel MR; Churchill TW J Electrocardiol; 2022; 72():13-15. PubMed ID: 35219112 [TBL] [Abstract][Full Text] [Related]
16. Cardiac screening before returning to elite sport after SARS-CoV-2 infection. Hédon C; Schnell F; Sosner P; Chagué F; Schuster I; Julia M; Duparc A; Guy JM; Molinari N; Michaux L; Cransac F; Cade S Arch Cardiovasc Dis; 2022 Nov; 115(11):562-570. PubMed ID: 36207245 [TBL] [Abstract][Full Text] [Related]
17. Italian return to play protocol after COVID-19 in young competitive and professional athletes: diagnostic yield and cost-benefit analysis. Sollazzo F; Pengue L; Monti R; DI Murro E; Cea G; Modica G; Manes S; Cammarano M; Pradella S; Bianco M; Zeppilli P; Palmieri V Minerva Cardiol Angiol; 2023 Jun; 71(3):233-241. PubMed ID: 36645387 [TBL] [Abstract][Full Text] [Related]
18. Long-term cardiac follow-up of athletes infected with SARS-CoV-2 after resumption of elite-level sports. van Hattum JC; Daems JJN; Verwijs SM; Wismans LV; van Diepen MA; Groenink M; Boekholdt SM; Planken RN; van Randen A; Hirsch A; Moen MH; Pinto YM; Wilde AAM; Jørstad HT Heart; 2024 Jan; 110(4):254-262. PubMed ID: 37678891 [TBL] [Abstract][Full Text] [Related]
20. Cardiac screening prior to return to play after SARS-CoV-2 infection: focus on the child and adolescent athlete: A Clinical Consensus Statement of the Task Force for Childhood Health of the European Association of Preventive Cardiology. D'Ascenzi F; Castelletti S; Adami PE; Cavarretta E; Sanz-de la Garza M; Maestrini V; Biffi A; Kantor P; Pieles G; Verhagen E; Tiberi M; Hanssen H; Papadakis M; Niebauer J; Halle M Eur J Prev Cardiol; 2022 Nov; 29(16):2120-2124. PubMed ID: 36059208 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]